Market Overview

UPDATE: Piper Jaffray Reduces PT to $67 on Albemarle on Bromine Derivatives Visibility

Related ALB
Albemarle Corporation Sets November 14 As Date Of Special Shareholder Meeting In Connection With Proposed Acquisition Of Rockwood Holdings
US Stock Futures Gain Ahead Of Consumer Data

Piper Jaffray reiterated its Overweight rating on Albemarle (NYSE: ALB) and lowered its price target from $72 to $67.

Piper Jaffray commented, "At this point, Albemarle is largely a 2013 story, with Fine Chemistry doubling capacity to keep pace and NBPT exhibiting robust growth, and Catalysts expecting a solid lead-in to 2013 on higher HPC volumes y/y. The larger question marks are olumes and pricing for bromine derivatives, for which we expect more clarity post Chinese New Year."

Albemarle closed at $55.33 on Friday.

Latest Ratings for ALB

DateFirmActionFromTo
Aug 2014MacquarieUpgradesNeutralOutperform
Aug 2014JefferiesMaintainsBuy
Aug 2014JP MorganMaintainsNeutral

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (ALB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters